From a molecular laboratory viewpoint, Relafen 750 (Naproxen) exhibits unique characteristics . It functions primarily as a cyclooxygenase drug , preferentially blocking cyclooxygenase-2 (COX-2), an catalyst participating in prostaglandin synthesis . This targeted inhibition results in decreased inflammation and ache, providing potential benefits f